{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:04:09Z","timestamp":1762142649648,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.ejphar.2008.11.055","type":"journal-article","created":{"date-parts":[[2008,12,5]],"date-time":"2008-12-05T05:53:53Z","timestamp":1228456433000},"page":"373-379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Adverse renal effects of hydrochlorothiazide in rats with myocardial infarction treated with an ACE inhibitor"],"prefix":"10.1016","volume":"602","author":[{"given":"Bart","family":"Westendorp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inge","family":"Hamming","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariusz K.","family":"Szymanski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerjan","family":"Navis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry","family":"van Goor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hendrik","family":"Buikema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wiek H.","family":"van Gilst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regien G.","family":"Schoemaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2008.11.055_bib1","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/ki.1992.390","article-title":"Reduced capillary density in the myocardium of uremic rats \u2013 a stereological study","volume":"42","author":"Amann","year":"1992","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2008.11.055_bib2","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1046\/j.1523-1755.2003.00927.x","article-title":"Cardiomyocyte loss in experimental renal failure: prevention by ramipril","volume":"63","author":"Amann","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2008.11.055_bib3","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/jat.2550100509","article-title":"Toxicology and carcinogenicity studies of diuretics in F344 rats and B6C3F1 mice. 1. Hydrochlorothiazide","volume":"10","author":"Bucher","year":"1990","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.ejphar.2008.11.055_bib4","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1093\/ndt\/13.7.1682","article-title":"The blunting of the antiproteinuric efficacy of ACE inhibition by high sodium intake can be restored by hydrochlorothiazide","volume":"13","author":"Buter","year":"1998","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ejphar.2008.11.055_bib5","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.amjcard.2006.08.007","article-title":"Dose-dependent association between use of loop diuretics and mortality in advanced systolic heart failure","volume":"98","author":"Chuen","year":"2006","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejphar.2008.11.055_bib6","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1097\/01.ASN.0000130154.42061.C6","article-title":"Increased infarct size in uremic rats: reduced ischemia tolerance?","volume":"15","author":"Dikow","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejphar.2008.11.055_bib7","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.amjcard.2005.12.072","article-title":"Relation of loop diuretic dose to mortality in advanced heart failure","volume":"97","author":"Eshaghian","year":"2006","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejphar.2008.11.055_bib8","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1681\/ASN.2004060505","article-title":"Diuretic and enhanced sodium restriction results in improved antiproteinuric response to RAS blocking agents","volume":"16","author":"Esnault","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejphar.2008.11.055_bib9","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.jacc.2003.06.001","article-title":"Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality","volume":"42","author":"Gibson","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2008.11.055_bib10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/path.1956","article-title":"ACE inhibition has adverse renal effects during dietary sodium restriction in proteinuric and healthy rats","volume":"209","author":"Hamming","year":"2006","journal-title":"J. Pathol."},{"key":"10.1016\/j.ejphar.2008.11.055_bib11","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/ki.1989.190","article-title":"Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril","volume":"36","author":"Heeg","year":"1989","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2008.11.055_bib12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1042\/cs0900031","article-title":"Cardiomegaly and vasoactive hormones in rats with chronic myocardial infarction: long-term effects of chlorothiazide","volume":"90","author":"Kohzuki","year":"1996","journal-title":"Clin. Sci. (Lond)"},{"key":"10.1016\/j.ejphar.2008.11.055_bib13","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1177\/074823378700300313","article-title":"Pathologic effects of chronic administration of hydrochlorothiazide, with and without sodium nitrite, to F344 rats","volume":"3","author":"Lijinsky","year":"1987","journal-title":"Toxicol. Ind. Health"},{"key":"10.1016\/j.ejphar.2008.11.055_bib14","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/ki.1996.426","article-title":"Thiazide treatment of rats provokes apoptosis in distal tubule cells","volume":"50","author":"Loffing","year":"1996","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2008.11.055_bib15","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/00005344-199202000-00017","article-title":"Renal structure and function in rats after suprapharmacologic doses of quinapril, an angiotensin-converting enzyme inhibitor","volume":"19","author":"MacDonald","year":"1992","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.11.055_bib16","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/00005344-198706000-00016","article-title":"Diuretic effects of angiotensin-converting enzyme inhibition: comparison of low and liberal sodium diet in hypertensive patients","volume":"9","author":"Navis","year":"1987","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.11.055_bib17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2131\/jts.29.37","article-title":"Renal effects of 26-week administration of olmesartan medoxomil\/hydrochlorothiazide in rats","volume":"29","author":"Ogata","year":"2004","journal-title":"J. Toxicol. Sci."},{"key":"10.1016\/j.ejphar.2008.11.055_bib18","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1093\/cvr\/27.11.1933","article-title":"Selective and time related activation of the cardiac renin\u2013angiotensin system after experimental heart failure: relation to ventricular function and morphology","volume":"27","author":"Pinto","year":"1993","journal-title":"Cardiovasc. Res."},{"issue":"Suppl 1","key":"10.1016\/j.ejphar.2008.11.055_bib19","first-page":"S13","article-title":"Dosing of ACE inhibitors in left ventricular dysfunction: does current clinical dosing provide optimal benefit?","volume":"34","author":"Pinto","year":"1999","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.11.055_bib20","first-page":"271","article-title":"Morphologic aspects of low-potassium and low-sodium nephropathy","volume":"19","author":"Riemenschneider","year":"1983","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.ejphar.2008.11.055_bib21","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.tem.2005.09.002","article-title":"Aldosterone: good guy or bad guy in cerebrovascular disease?","volume":"16","author":"Rigsby","year":"2005","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2008.11.055_bib22","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1161\/01.CIR.0000095676.90936.80","article-title":"Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention","volume":"108","author":"Sarnak","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2008.11.055_bib23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00005344-199607000-00003","article-title":"Acute and long-term dose\u2013response study of quinapril on hormonal profile and tissue angiotensin-converting enzyme in Wistar rats","volume":"28","author":"Schaison","year":"1996","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.11.055_bib24","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1053\/euhj.2001.2989","article-title":"The prognostic importance of creatinine clearance after acute myocardial infarction","volume":"23","author":"Sorensen","year":"2002","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejphar.2008.11.055_bib25","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1161\/01.CIR.0000149806.01354.BF","article-title":"Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the Survival And Ventricular Enlargement (SAVE) study","volume":"110","author":"Tokmakova","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2008.11.055_bib26","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/S0735-1097(98)00464-1","article-title":"High- versus low-dose ACE inhibition in chronic heart failure: a double-blind, placebo-controlled study of imidapril","volume":"32","author":"van Veldhuisen","year":"1998","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2008.11.055_bib27","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1681\/ASN.2007060693","article-title":"Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan","volume":"19","author":"Vogt","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejphar.2008.11.055_bib28","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.ejheart.2004.12.002","article-title":"Beneficial effects of add-on hydrochlorothiazide in rats with myocardial infarction optimally treated with quinapril","volume":"7","author":"Westendorp","year":"2005","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ejphar.2008.11.055_bib29","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ejphar.2005.10.019","article-title":"Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: differential effects on lisinopril and zofenopril","volume":"527","author":"Westendorp","year":"2005","journal-title":"Eur. J. Pharmacol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299908012016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299908012016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:00:00Z","timestamp":1762142400000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299908012016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":29,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0014299908012016"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2008.11.055","relation":{},"ISSN":["0014-2999"],"issn-type":[{"type":"print","value":"0014-2999"}],"subject":[],"published":{"date-parts":[[2009,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adverse renal effects of hydrochlorothiazide in rats with myocardial infarction treated with an ACE inhibitor","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2008.11.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}